During the past decade, Institut Hospital del Mar d'Investigacions Mèdiques conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Hospital del Mar d'Investigacions Mèdiques" #1 sponsor was "Parc de Salut Mar" with 11 trials, followed by "Sierra Oncology, Inc." with 2 trials sponsored, "FIDMAG Germanes Hospitalàries" with 1 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored and "King's College London" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Hospital del Mar d'Investigacions Mèdiques" #1 collaborator was "Instituto de Salud Carlos III" with 3 trials as a collaborator, "Aelis Farma" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Barcelonabeta Brain Research Center, Pasqual Maragall Foundation" with 1 trials as a collaborator and "Berry Consultants" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Institut Hospital del Mar d'Investigacions Mèdiques" are "Down Syndrome" (3 trials), "Alcohol-Related Disorders" (2 trials), "Amphetamine-Related Disorders" (2 trials), "Healthy" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Institut Hospital del Mar d'Investigacions Mèdiques" in a lesser frequency.

Most popular intervention types in "Institut Hospital del Mar d'Investigacions Mèdiques" are "Drug" (8 trials), "Dietary Supplement" (5 trials), "Other" (5 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Alcohol" (2 trials), "Mephedrone" (2 trials), "3,4-methylenedioxymethamphetamine" (1 trials) and "ARB + DMX-200" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Hospital del Mar d'Investigacions Mèdiques" are 13 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institut Hospital del Mar d'Investigacions Mèdiques". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Institut Hospital del Mar d'Investigacions Mèdiques, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Hospital del Mar d'Investigacions Mèdiques, 6 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Institut Hospital del Mar d'Investigacions Mèdiques has several departments that took part in Clinical trials: "IMIM, Human Pharmacology and Clinical Neurosciences," - 3 trials